Contact Us

New Stories

• NuNerve launches 75-patient Phase 2 MND trial of NUN-004

  November 10, 2026 - - Latest News

• Tetratherix moves to new royalty arrangement with the University of Sydney

  November 10, 2026 -

• AVITA Medical raises guidance as Medicare locks in RECELL payment codes

  November 9, 2026 - - Latest News

• Nexsen targets 2027 FDA filing for bedside kidney injury test

  November 9, 2026 - - Latest News

• CLINUVEL bets its cash reserves on long acting injectables and a possible US listing

  November 9, 2026 - - Latest News

• Miro Sciences maps path to Phase 2 trial of stem cell therapy for severe Crohn's disease

  November 5, 2026 - - Latest News

• Recce director Alistair McKeough to retire at AGM after eight years

  November 5, 2026 - - Latest News